# A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

> **NCT00619931** · PHASE1 · COMPLETED · sponsor: **Arena Pharmaceuticals** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** APD791

## Key facts

- **NCT ID:** NCT00619931
- **Lead sponsor:** Arena Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619931, "A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00619931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*